Dopaminergic inhibition of striatal cholinergic neurons: Synergistic blocking action of ?-butyrolactone and neuroleptic drugs
- 1 January 1974
- journal article
- Published by Springer Nature in Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie
- Vol. 283 (2), 129-134
- https://doi.org/10.1007/bf00501139
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- The release of acetylcholine from the brain: An approach to the study of the central cholinergic mechanismsProgress in Neurobiology, 1973
- Enhanced striatal acetylcholine release by chlorpromazine and its reversal by apomorphineBrain Research, 1973
- The release of H3-dopamine from cat brain following electrical stimulation of the substantia nigra and caudate nucleusNeuropharmacology, 1971
- Kritische Stellungnahme zum Begriff der NeuroleptikaPharmacopsychiatry, 1971
- Effect of anesthetic doses of γ-hydroxybutyrate on subcortical concentrations of homovanillic acidEuropean Journal of Pharmacology, 1971
- Receptor activity and turnover of dopamine and noradrenaline after neurolepticsEuropean Journal of Pharmacology, 1970
- Selective increase of brain dopamine induced by gamma-hydroxybutyrateLife Sciences, 1966
- Differential Estimation of Gamma-butyrolactone and Gamma-hydroxybutyric Acid in Rat Blood and BrainScience, 1964
- Effects of chlorpromazine, haloperidol and reserpine on the levels of phenolic acids in rabbit corpus striatumLife Sciences, 1964
- Effect of Chlorpromazine or Haloperidol on Formation of 3‐Methoxytyramine and Normetanephrine in Mouse BrainActa Pharmacologica et Toxicologica, 1963